(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ: ARCT) rose by a staggering 24.49% in 14 days from $16.62 to $20.69 at 15:07 EST on Monday, after three consecutive sessions in a row of gains. NASDAQ is falling 0.12% to $12,642.78, following the last session’s downward trend.
Arcturus Therapeutics’s last close was $22.13, 65.95% under its 52-week high of $65.00.
Today’s last reported volume for Arcturus Therapeutics is 279959 which is 56.22% below its average volume of 639561.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 51.9% for the current quarter and a decline by 42.1% for the next. The company’s growth estimates for the current quarter and the next is 15.5% and 22.4%, respectively.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 158.9%, now sitting on 12.36M for the twelve trailing months.
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 6.18%, 0.31%, and 6.85%, respectively.
Arcturus Therapeutics’s highest amplitude of average volatility was 6.49% (last week), 4.80% (last month), and 6.85% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be oversold (<=20).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $20.69 at 15:07 EST, way below its 52-week high of $65.00 and way higher than its 52-week low of $11.70.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s value is way above its 50-day moving average of $17.03 and way below its 200-day moving average of $27.09.
More news about Arcturus Therapeutics (ARCT).